Lifestyle
Meowzempic is here. Experts estimate that more than half of the world’s pet cats are overweight — and now the flabby tabbies might soon have their own version of Ozempic. Pet meds company OKAVA Pharmaceuticals has announced that the first clinical trial — dubbed MEOW-1 (ManagEment of OverWeight cats with OKV-119) — for a feline GLP-1 agonist drug was a success. The pet-tailored GLP-1 has the potential to enhance quality of life, promote healthy aging and even become the “most impactful life-extending therapy” available for felines, according to a press release. Beyond simply weight loss, the drug could be the…
An American sex therapist and podcaster, who claims she went through a “terrifying” 72 hours…
It’s time to clear the air. While staying inside seems like a safe way to…
New York Post may be compensated and/or receive an affiliate commission if you click or…
A McDonald’s worker has lifted the veil on the mysterious McRib. Since its 1981 inception,…
Parents are scrambling to secure a cheap generic cancer drug for their children after the…
A brand-new sugar-free Oreo variety is set to hit grocery shelves across the country in January 2026…
NEWYou can now listen to Fox News articles! NEW DETAILS – Amelia Earhart documents were…
New York Post may be compensated and/or receive an affiliate commission if you click or…
New York Post may be compensated and/or receive an affiliate commission if you click or…
It’s sequin season again! And with New Year’s Eve just around the corner, that means…
Anything is pastable. When Forma Pasta Factory first opened its doors in Greenpoint, Brooklyn, in…
A California social media influencer is facing backlash for having a “decolonized Christmas” as she…
2025 © Prices.com LLC. All Rights Reserved.